DK1194415T3 - Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling - Google Patents
Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstillingInfo
- Publication number
- DK1194415T3 DK1194415T3 DK00944119T DK00944119T DK1194415T3 DK 1194415 T3 DK1194415 T3 DK 1194415T3 DK 00944119 T DK00944119 T DK 00944119T DK 00944119 T DK00944119 T DK 00944119T DK 1194415 T3 DK1194415 T3 DK 1194415T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- preparation
- new
- piperazinylalkylthiopyrimidine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902214A HU9902214D0 (en) | 1999-06-29 | 1999-06-29 | Novel piperazinyl-alkyl-thio-pyrimidine-derivatives, process for producing them and medicaments containing the same |
HU0002156A HU227402B1 (en) | 2000-06-06 | 2000-06-06 | Novel piperazinyl alkylthio pyrimidinyl derivatives, pharmaceutical compositions containing such active ingredients and process for producing the active ingredients |
PCT/HU2000/000064 WO2001000617A2 (en) | 1999-06-29 | 2000-06-29 | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1194415T3 true DK1194415T3 (da) | 2003-12-08 |
Family
ID=89998587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00944119T DK1194415T3 (da) | 1999-06-29 | 2000-06-29 | Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling |
Country Status (19)
Country | Link |
---|---|
US (1) | US6469168B1 (zh) |
EP (1) | EP1194415B1 (zh) |
JP (1) | JP2003503404A (zh) |
KR (1) | KR20020016872A (zh) |
CN (1) | CN1173956C (zh) |
AT (1) | ATE247645T1 (zh) |
AU (1) | AU5835400A (zh) |
CA (1) | CA2376307A1 (zh) |
CZ (1) | CZ20014575A3 (zh) |
DE (1) | DE60004671T2 (zh) |
DK (1) | DK1194415T3 (zh) |
ES (1) | ES2204643T3 (zh) |
HK (1) | HK1046902A1 (zh) |
HR (1) | HRP20010969B1 (zh) |
PL (1) | PL352476A1 (zh) |
PT (1) | PT1194415E (zh) |
RU (1) | RU2245334C2 (zh) |
SK (1) | SK285670B6 (zh) |
WO (1) | WO2001000617A2 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003246587A1 (en) | 2002-07-02 | 2004-01-23 | F. Hoffmann-La Roche Ag | 2, 5-substituted pyrimidine derivatives as ccr-3 receptor antagonists ix |
US11351168B1 (en) | 2008-06-27 | 2022-06-07 | Celgene Car Llc | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
WO2009158571A1 (en) | 2008-06-27 | 2009-12-30 | Avila Therapeutics And Uses Thereof | Heteroaryl compounds and uses thereof |
WO2012021444A1 (en) * | 2010-08-10 | 2012-02-16 | Avila Therapeutics, Inc. | Besylate salt of a btk inhibitor |
TWI545115B (zh) | 2010-11-01 | 2016-08-11 | 阿維拉製藥公司 | 雜環化合物及其用途 |
WO2012061303A1 (en) | 2010-11-01 | 2012-05-10 | Avila Therapeutics, Inc. | Heteroaryl compounds and uses thereof |
JP5957003B2 (ja) | 2010-11-10 | 2016-07-27 | セルジーン アヴィロミクス リサーチ, インコーポレイテッド | 変異体選択的egfr阻害剤およびその使用 |
AR088570A1 (es) | 2011-10-28 | 2014-06-18 | Celgene Avilomics Res Inc | Metodos para tratar una enfermedad o trastorno relacionado con la tirosina quinasa de bruton |
WO2013138495A1 (en) | 2012-03-15 | 2013-09-19 | Celgene Avilomics Research, Inc. | Solid forms of an epidermal growth factor receptor kinase inhibitor |
EP2825042B1 (en) | 2012-03-15 | 2018-08-01 | Celgene CAR LLC | Salts of an epidermal growth factor receptor kinase inhibitor |
WO2014100748A1 (en) | 2012-12-21 | 2014-06-26 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
JP2016509012A (ja) | 2013-02-08 | 2016-03-24 | セルジーン アビロミクス リサーチ, インコーポレイテッド | Erk阻害剤およびそれらの使用 |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
WO2016025561A1 (en) | 2014-08-13 | 2016-02-18 | Celgene Avilomics Research, Inc. | Forms and compositions of an erk inhibitor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT76266A (en) | 1995-10-31 | 1997-07-28 | Egyt Gyogyszervegyeszeti Gyar | New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components |
-
2000
- 2000-06-29 PL PL00352476A patent/PL352476A1/xx unknown
- 2000-06-29 US US10/009,675 patent/US6469168B1/en not_active Expired - Fee Related
- 2000-06-29 CA CA002376307A patent/CA2376307A1/en not_active Abandoned
- 2000-06-29 KR KR1020017016917A patent/KR20020016872A/ko not_active Application Discontinuation
- 2000-06-29 WO PCT/HU2000/000064 patent/WO2001000617A2/en not_active Application Discontinuation
- 2000-06-29 JP JP2001507025A patent/JP2003503404A/ja active Pending
- 2000-06-29 SK SK1927-2001A patent/SK285670B6/sk unknown
- 2000-06-29 DE DE60004671T patent/DE60004671T2/de not_active Expired - Fee Related
- 2000-06-29 CN CNB008096635A patent/CN1173956C/zh not_active Expired - Fee Related
- 2000-06-29 AU AU58354/00A patent/AU5835400A/en not_active Abandoned
- 2000-06-29 CZ CZ20014575A patent/CZ20014575A3/cs unknown
- 2000-06-29 AT AT00944119T patent/ATE247645T1/de not_active IP Right Cessation
- 2000-06-29 ES ES00944119T patent/ES2204643T3/es not_active Expired - Lifetime
- 2000-06-29 PT PT00944119T patent/PT1194415E/pt unknown
- 2000-06-29 EP EP00944119A patent/EP1194415B1/en not_active Expired - Lifetime
- 2000-06-29 RU RU2002102551/04A patent/RU2245334C2/ru not_active IP Right Cessation
- 2000-06-29 DK DK00944119T patent/DK1194415T3/da active
-
2001
- 2001-12-28 HR HR20010969A patent/HRP20010969B1/xx not_active IP Right Cessation
-
2002
- 2002-10-10 HK HK02107406.1A patent/HK1046902A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
RU2245334C2 (ru) | 2005-01-27 |
HRP20010969B1 (en) | 2005-04-30 |
DE60004671T2 (de) | 2004-07-29 |
PL352476A1 (en) | 2003-08-25 |
SK19272001A3 (sk) | 2002-05-09 |
WO2001000617A2 (en) | 2001-01-04 |
CZ20014575A3 (cs) | 2002-04-17 |
ES2204643T3 (es) | 2004-05-01 |
CN1173956C (zh) | 2004-11-03 |
WO2001000617A3 (en) | 2001-03-01 |
HRP20010969A2 (en) | 2003-04-30 |
EP1194415A2 (en) | 2002-04-10 |
SK285670B6 (sk) | 2007-06-07 |
KR20020016872A (ko) | 2002-03-06 |
AU5835400A (en) | 2001-01-31 |
EP1194415B1 (en) | 2003-08-20 |
ATE247645T1 (de) | 2003-09-15 |
CA2376307A1 (en) | 2001-01-04 |
US6469168B1 (en) | 2002-10-22 |
PT1194415E (pt) | 2004-01-30 |
JP2003503404A (ja) | 2003-01-28 |
DE60004671D1 (de) | 2003-09-25 |
CN1359375A (zh) | 2002-07-17 |
HK1046902A1 (zh) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS74904A (en) | Substituted pyridinones as modulators of p38 map kinase | |
DK1194415T3 (da) | Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling | |
NO972910L (no) | Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister | |
BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
NO20055092L (no) | Substituerte pyrimidioner | |
IS1904B (is) | Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum | |
PT97689A (pt) | Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida | |
WO2005018557A3 (en) | Substituted pyridinones | |
NO20055219L (no) | Nye forbindelser | |
NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
GEP20022678B (en) | Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors, their Pharmaceutical compositions and methods for Treatment | |
BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
FI963294A0 (fi) | Naftyyliamidit keskushermostoaineina | |
NO20021859D0 (no) | Nye digosakkarider, deres fremstilling samt farmasöytiske preparater | |
ES2328496T3 (es) | Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos. | |
NO20020282D0 (no) | Nytt difenylpiperidinderivat | |
BRPI0418255A (pt) | derivados de piperazina e piperidina n-substituìdos | |
DE60121431D1 (de) | Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
AU5692500A (en) | Piperazine derivatives as modulators of chemokine receptor activity | |
NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
FI905957A (fi) | Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet. | |
NO20000423D0 (no) | Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene | |
PT1025101E (pt) | Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central | |
NO20063353L (no) | 1,2,3,4-tetrahydroisokinolinderivater, fremgangsmate for fremstilling derav og anvendelser derav |